158 related articles for article (PubMed ID: 20352292)
41. Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors.
Eissa IH; Metwaly AM; Belal A; Mehany ABM; Ayyad RR; El-Adl K; Mahdy HA; Taghour MS; El-Gamal KMA; El-Sawah ME; Elmetwally SA; Elhendawy MA; Radwan MM; ElSohly MA
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900123. PubMed ID: 31463953
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and antiproliferative activity of 9-benzylamino-6-chloro-2-methoxy-acridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.
Zhang W; Zhang B; Zhang W; Yang T; Wang N; Gao C; Tan C; Liu H; Jiang Y
Eur J Med Chem; 2016 Jun; 116():59-70. PubMed ID: 27060757
[TBL] [Abstract][Full Text] [Related]
43. Induction of apoptosis through caspase-independent or caspase-9-dependent pathway in mouse and human osteosarcoma cells by a new nitroxyl spin-labeled derivative of podophyllotoxin.
Yang TM; Qi SN; Zhao N; Yang YJ; Yuan HQ; Zhang B; Jin S
Apoptosis; 2013 Jun; 18(6):727-38. PubMed ID: 23430060
[TBL] [Abstract][Full Text] [Related]
44. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
45. 4'-Demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum exhibits potential anticancer activities by altering Chk-2 signaling pathway in MCF-7 breast cancer cells.
Zilla MK; Nayak D; Amin H; Nalli Y; Rah B; Chakraborty S; Kitchlu S; Goswami A; Ali A
Chem Biol Interact; 2014 Dec; 224():100-7. PubMed ID: 25446499
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and evaluation of the cell cycle arrest and CT DNA interaction properties of 4β-amino-4'-O-demethyl-4-deoxypodophyllotoxins.
Liu JF; Sang CY; Qin WW; Zhao J; Hui L; Ding YL; Chen SW
Bioorg Med Chem; 2013 Nov; 21(22):6948-55. PubMed ID: 24095019
[TBL] [Abstract][Full Text] [Related]
47. Design and synthesis of novel 4'-demethyl-4-deoxypodophyllotoxin derivatives as potential anticancer agents.
Zhu X; Fu J; Tang Y; Gao Y; Zhang S; Guo Q
Bioorg Med Chem Lett; 2016 Feb; 26(4):1360-4. PubMed ID: 26804229
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
[TBL] [Abstract][Full Text] [Related]
49. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor.
Yang F; Chen Y; Duan W; Zhang C; Zhu H; Ding J
Int J Cancer; 2006 Sep; 119(5):1184-93. PubMed ID: 16570288
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.
Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881
[TBL] [Abstract][Full Text] [Related]
51. Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage.
Gieseler F; Bauer E; Nuessler V; Clark M; Valsamas S
Leukemia; 1999 Nov; 13(11):1859-63. PubMed ID: 10557063
[TBL] [Abstract][Full Text] [Related]
52. Dicentrine Analogue-Induced G2/M Arrest and Apoptosis through Inhibition of Topoisomerase II Activity in Human Cancer Cells.
Lin HF; Huang HL; Liao JF; Shen CC; Huang RL
Planta Med; 2015 Jul; 81(10):830-7. PubMed ID: 26158522
[TBL] [Abstract][Full Text] [Related]
53. B1, a novel topoisomerase II inhibitor, induces apoptosis and cell cycle G1 arrest in lung adenocarcinoma A549 cells.
Cheng MH; Yang YC; Wong YH; Chen TR; Lee CY; Yang CC; Chen SH; Yang IN; Yang YS; Huang HS; Yang CY; Huang MS; Chiu HF
Anticancer Drugs; 2012 Feb; 23(2):191-9. PubMed ID: 22008852
[TBL] [Abstract][Full Text] [Related]
54. Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer.
Chien CM; Yang JC; Wu PH; Wu CY; Chen GY; Wu YC; Chou CK; Tseng CH; Chen YL; Wang LF; Chiu CC
Phytomedicine; 2019 Feb; 54():109-119. PubMed ID: 30668360
[TBL] [Abstract][Full Text] [Related]
55. Antitumor agents, 107. New cytotoxic 4-alkylamino analogues of 4'-demethyl-epipodophyllotoxin as inhibitors of human DNA topoisomerase II.
Lee KH; Imakura Y; Haruna M; Beers SA; Thurston LS; Dai HJ; Chen CH; Liu SY; Cheng YC
J Nat Prod; 1989; 52(3):606-13. PubMed ID: 2550587
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of 4β-N-polyaromatic substituted podophyllotoxins: DNA topoisomerase inhibition, anticancer and apoptosis-inducing activities.
Kamal A; Kumar BA; Suresh P; Agrawal SK; Chashoo G; Singh SK; Saxena AK
Bioorg Med Chem; 2010 Dec; 18(24):8493-500. PubMed ID: 21074444
[TBL] [Abstract][Full Text] [Related]
57. DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.
Qiao F; Zuo D; Shen X; Qi H; Wang H; Zhang W; Wu Y
Cancer Chemother Pharmacol; 2012 Aug; 70(2):259-70. PubMed ID: 22752214
[TBL] [Abstract][Full Text] [Related]
58. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
59. Triazole/thiadiazole substituted 4'-demethylepipodophyllotoxin derivatives induced apoptosis in HeLa cells by up-regulating TMEM133.
Zhao W; Duan Y; Li HM; Li S; Shen Y; Zhang Y; Li YZ; Tang YJ
Eur J Pharmacol; 2021 Aug; 905():174189. PubMed ID: 34033816
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin.
Zhao Y; Wang C; Wu Z; Fang J; Zhu L
Invest New Drugs; 2012 Feb; 30(1):17-24. PubMed ID: 20697773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]